National Cancer Institute
Best Case Series Program
The National Cancer Institute (NCI) is committed to finding innovative, promising treatments for people with cancer. As part of the Division of Cancer Treatment and Diagnosis (DCTD), the NCI’s Office of Cancer Complementary and Alternative Medicine (OCCAM) coordinates the Institute’s research program in complementary and alternative medicine (CAM). Since its inception in 1991, the NCI Best Case Series Program has had a process for evaluating patient data from CAM practitioners around the world. Through OCCAM’s Case Review and Intramural Science Program (CRISP), the process involves the same rigorous scientific methods employed in evaluating treatment responses with conventional medicine and provides an independent retrospective review of medical records and medical imaging from patients treated with alternative cancer therapies.
For more information of the NCI Best Case Series Program visit the web page below:
NCI BCS Protocol